Christopher Martin

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Oruka Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ORKA alerts

About Christopher Martin

Christopher Martin is recorded as Board Member at Oruka Therapeutics, Inc. (ORKA) since December 11, 2025. Oruka Therapeutics, Inc. reported in an 8-K filed December 11, 2025 that Christopher Martin was appointed Class II director, effective December 11, 2025. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Thomas A. Keuer (CEO), Samarth Kulkarni (Chairman and Board Member) and 7 others.

“On December 11, 2025, the Board appointed Christopher Martin to serve as a Class II director, with a term expiring at the Company's 2026 annual meeting of stockholders.”

Oruka Therapeutics, Inc. Form 8-K, filed December 11, 2025 · Read the filing

Affiliation history

Oruka Therapeutics, Inc. (ORKA)
Board Member

SEC 8-K

Current
2025-12-11–present

Company network

Oruka Therapeutics, Inc.

ORKA

Current role

Biotechnology · Healthcare

Board Member

2025-12-11–present

Leadership on record at Oruka Therapeutics, Inc.

Lawrence Klein CEO, Board Member
Thomas A. Keuer CEO
Samarth Kulkarni Chairman, Board Member
C. Jeff Dekker CFO
C. Jeffrey Dekker CFO
Laura Sandler COO
Paul Quinlan General Counsel
Anders Hove Board Member
Cameron Turtle Board Member
Carl Dambkowski Board Member

Recent activity

Executive change Appointed: Class II director Oruka Therapeutics, Inc. (ORKA)
2025-12-11